14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
A group of 18 state attorneys general (the “AGs”) recently filed comments with the Federal Trade C...
Read More >
Supreme Court Confirms When an Employee is Entitled to Legal Representation - Precedential Decision...
Read More >
A local air district is developing a rule that would require both existing and proposed warehouses t...
Read More >
SEC Chair Jay Clayton is reduced to having a PR firm create fake investor letters to support a SEC r...
Read More >
A recent Delaware Court of Chancery decision confirms that, unlike in statutory mergers, the attorne...
Read More >
The National Labor Relations Board (“NLRB”) has been busy this summer—issuing two significant dec...
Read More >